Picture of Virpax Pharmaceuticals logo

VRPX — Virpax Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Virpax Announces Positive Results For The Swine Model Dose Range Finding Study For Probudur™

Nov 22 (Reuters) - Range Resources Corp  RRC.N :
    * VIRPAX ANNOUNCES POSITIVE RESULTS FOR THE SWINE MODEL DOSE
RANGE
FINDING STUDY FOR PROBUDUR™
    * VIRPAX PHARMACEUTICALS INC - MINIPIGS SHOW POSITIVE
TOLERANCE TO
PROBUDUR WITH NO ADVERSE EFFECTS

Source text:  ID:nBwm5NRVa 
Further company coverage:  RRC.N 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Virpax Pharmaceuticals

See all news